Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction

被引：0
|
作者：
Hasan Ali Barman
Selim Tanyolaç
Omer Dogan
Erdem Bal
Adem Atıcı
Serhan Özyıldırım
Zerrin Yiğit
机构：
[1] Istanbul University-Cerrahpaşa,Department of Cardiology, Institute of Cardiology
[2] Goztepe Training and Research Hospital,Department of Cardiology, Faculty of Medicine
[3] Istanbul Medeniyet University,undefined
来源：
Clinical Drug Investigation | 2022年 / 42卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：533 / 540
页数：7
相关论文
共 50 条
  • [1] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Barman, Hasan Ali
    Tanyolac, Selim
    Dogan, Omer
    Bal, Erdem
    Atici, Adem
    Ozyildirim, Serhan
    Yigit, Zerrin
    [J]. CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 533 - 540
  • [2] Impact of sacubitril/valsartan on echo parameters in heart failure patients with reduced ejection fraction a prospective evaluation
    Bayard, Geoffrey
    Da Costa, Antoine
    Pierrard, Romain
    Romeyer-Bouchard, Cecile
    Guichard, Jean Baptiste
    Isaaz, Karl
    [J]. IJC HEART & VASCULATURE, 2019, 25
  • [3] Sacubitril/Valsartan in Asian Patients with Heart Failure with Reduced Ejection Fraction
    Dewan, Pooja
    Docherty, Kieran F.
    McMurray, John J., V
    [J]. KOREAN CIRCULATION JOURNAL, 2019, 49 (06) : 469 - 484
  • [4] Influence of sacubitril/valsartan on diastolic parameters in patients with chronic heart failure with reduced ejection fraction
    Uzokov, J.
    Mukhamedova, M. G.
    Narzullaeva, D. S.
    Nosirova, G. A.
    Orziev, D. Z.
    Majidov, I
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (SUPP_1) : I19 - I19
  • [5] Use of Sacubitril/Valsartan in heart failure with reduced ejection fraction
    吴利强
    冯慧婷
    冯慧娟
    [J]. South China Journal of Cardiology, 2019, 20 (04) : 252 - 257
  • [6] Impact of Sacubitril–Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction
    Pere Pericas
    Caterina Mas-Lladó
    Maria Francisca Ramis-Barceló
    Isabel Valadrón
    Marta Noris Mora
    Lucía Pasamar Márquez
    Rosa González Colino
    José Francisco Forteza Albertí
    Vicente Peral Disdier
    Xavier Rossello
    [J]. High Blood Pressure & Cardiovascular Prevention, 2021, 28 : 167 - 175
  • [7] Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
    Lee, Ying-Hsiang
    Lin, Po-Lin
    Chiou, Wei-Ru
    Huang, Jin-Long
    Lin, Wen-Yu
    Liao, Chia-Te
    Chung, Fa-Po
    Liang, Huai-Wen
    Hsu, Chien-Yi
    Chang, Hung-Yu
    [J]. ESC HEART FAILURE, 2021, 8 (02): : 1204 - 1215
  • [8] Association of Sacubitril/Valsartan with Metabolic Parameters in Patients with Reduced Ejection Fraction Heart Failure at a Multidisciplinary Clinic
    Ryu, Rachel
    Tran, Huyentran
    Bahjri, Khaled
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2021, 19 (02) : 115 - 118
  • [9] Sacubitril/Valsartan Improves Autonomic Function and Cardiopulmonary Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Giallauria, Francesco
    Vitale, Giuseppe
    Pacileo, Mario
    Di Lorenzo, Anna
    Oliviero, Alessandro
    Passaro, Francesco
    Calce, Roberta
    Parlato, Alessandro
    Testa, Crescenzo
    D'Ambrosio, Giuseppe
    Romano, Giuseppe
    Clemenza, Francesco
    Sarullo, Silvia
    Venturini, Elio
    Gentile, Marco
    Nugara, Cinzia
    Iannuzzo, Gabriella
    DAndrea, Antonello
    Vigorito, Carlo
    Sarullo, Filippo M.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06) : 1 - 15
  • [10] Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction
    Dereli, Seckin
    Kilincel, Oguzhan
    Cerik, Idris Bugra
    Kaya, Ahmet
    [J]. ACTA CARDIOLOGICA, 2020, 75 (08) : 774 - 782
12345